Cleo Salisbury

Cleo Salisbury is currently the Global MSAT Leader at Genentech, where they drive quality, speed, and agility in CMC and technical development for biologics. Previously, Cleo served as a Technical Development Team Leader at Genentech, managing CMC strategies for clinical drug candidates. Their experience also includes roles as a Research Scientist at Novartis and a Biochemistry Instructor at UC Berkeley Extension. Cleo earned a BS in Geology-Chemistry from Brown University and a PhD in Chemistry from the University of California, Berkeley.